Search for susceptibility alleles to lung cancer by screening familial cases for constitutional mutations in the Xeroderma Pigmentosum Complementation genes

被引：0
|
作者：
Matakidou, A [1 ]
Eisen, T [1 ]
Bridle, H [1 ]
Houlston, R [1 ]
机构：
[1] Inst Canc Res, Sutton, Surrey, England
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80581-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 28 条
  • [21] Screening for founder mutations in BRCA1/2 tumor susceptibility genes among breast cancer families from North Sardinia.
    Pisano, M
    Cossu, A
    Palomba, G
    Sarobba, MG
    Farris, A
    Dedola, MF
    Olmeo, N
    Contu, A
    Persico, I
    Satta, MP
    Ibba, M
    Stratton, MR
    Pirastu, M
    Tanda, F
    Palmieri, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 256 - 256
  • [22] Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes
    Johnston, Jennifer J.
    Rubinstein, Wendy S.
    Facio, Flavia M.
    Ng, David
    Singh, Larry N.
    Teer, Jamie K.
    Mullikin, James C.
    Biesecker, Leslie G.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 91 (01) : 97 - 108
  • [23] Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancer cases excludes additional high-impact susceptibility genes
    Loveday, C.
    Garrett, A.
    Law, P.
    Hanks, S.
    Poyastro-Pearson, E.
    Eccles, D.
    Evans, G.
    Snape, K.
    Hanson, H.
    Houlston, R.
    Turnbull, C.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S39 - S39
  • [24] Analysis of single nucleotide polymorphisms (SNPs) of cytidine deaminase (CDA) and xeroderma pigmentosum group D (XPD) genes for the prediction of clinical response to gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) patients.
    Vasile, E. =
    Giovannetti, E.
    Tibaldi, C.
    Mey, V.
    Nannizzi, S.
    Landi, L.
    Stasi, I.
    Danesi, R.
    Del Tacca, M.
    Falcone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 418S - 418S
  • [25] Analysis of rare disruptive germline mutations in 2,135 enriched BRCA-negative breast cancer cases excludes additional high-impact susceptibility genes
    Loveday, Chey
    Garrett, Alice
    Law, Philip
    Eccles, Diana
    Evans, D. Gareth
    Snape, Katie
    Hanson, Helen
    Houlston, Richard S.
    Turnbull, Clare
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 592 - 592
  • [26] EGFR mutations in non-small-cell lung cancer:: Analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment
    Marchetti, A
    Martella, C
    Felicioni, L
    Barassi, F
    Salvatore, S
    Chella, A
    Camplese, PP
    Iarussi, T
    Mucilli, F
    Mezzetti, A
    Cuccurullo, F
    Sacco, R
    Buttitta, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 857 - 865
  • [27] POTENTIAL PROGNOSTIC ROLE OF SOMATIC MUTATIONS IN SET OF CANCER SUSCEPTIBILITY GENES AND POLY ADP-RIBOSE POLYMERASE (PARP) EXPRESSION IN SURFACE EPITHELIAL OVARIAN CARCINOMA CASES: A FOLLOW-UP STUDY FROM PAKISTAN
    Masood, Atika
    Sarfraz, Rahat
    Khaliq, Saba
    Naseem, Nadia
    Shami, Amira
    Zaki, Saima
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A301 - A302
  • [28] Correlation of cytidine deaminase (CDA), xeroderma pigmentosum group D (XPD) and excision repair cross-complementing 1 (ERCC1) genes single nucleotide polymorphisms (SNPS) with response and survival in gemcitabine/cisplatin treated advanced non-small-cell lung cancer (NSCLC) patients
    Tibaldi, Carmelo
    Giovannetti, Elisa
    Vasile, Enrico
    Mey, Valentina
    Nannizzi, Sara
    Lo Dico, Monica
    Orlandini, Cinzia
    Del Tacca, Mario
    Falcone, Alfredo
    Danesi, Romano
    ANNALS OF ONCOLOGY, 2007, 18 : 33 - 33
123